Almac Successfully Moves its Clinical Technologies Business Unit into New North American Headquarters
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: 1 minute
Almac announced that its Clinical Technologies division has successfully moved into the Almac Group’s new North American Headquarters. After groundbreaking of the 40-acre site in Souderton, PA on 23 July 2008, the drug development firm has now completed the first phase of relocating employees from three Almac business units to the new 240,000 square feet integrated drug development facility.
On 11 October, Almac’s technology business unit joined employees from Almac’s analytical testing and clinical supplies units as occupants at the North American Headquarters. Over the course of the next two months, Almac will transition the remainder of its clinical supplies operations currently located in Audubon, PA, into the integrated drug development facility in Souderton, PA.
The transition of the technologies business into Almac’s new North American Headquarters was carefully planned and executed. Over the course of the past few months, Almac successfully relocated and tested all of its new and existing technologies and systems in the new locale to make certain that there were no disruptions to client studies during the transition into the North American Headquarters.
Jim Murphy, President of Almac’s clinical technologies business unit, comments on the flawless move of the business from Yardley, PA, to its new location in Souderton, PA. Murphy: “Our IT, Quality Assurance, senior management team, and other key personnel worked in unison to ensure that all of our systems were tested and met the highest standards before we moved into the new facility. The transition team’s meticulous planning enabled us to avoid any downtime on client studies outside of our normal maintenance windows. I am delighted to announce that everything went as planned with this perfectly executed transition.”
The move of three Almac business units to a new North American Headquarters is part of the Almac Group’s integrated services solutions strategy. The new facility was planned to deliver a full-service, integrated drug supply management and technology solution to biopharmaceutical clients.
Joseph Bedford, Ph.D., Director of Marketing at Almac’s Clinical Technologies business unit comments: “The biopharmaceutical industry is making great strides to streamline drug development and bring efficiencies to clinical trials. Our new North American Headquarters allows Almac to deliver an integrated clinical supplies, analytical testing, and clinical technologies offering to sponsors that is unparalleled in our industry. Working with integrated teams of drug supply management and technology specialists at Almac, our clients will benefit from the combined insights of experienced professionals who deliver efficiencies in the clinical supplies chain that no other firm can match.”
On 11 October, Almac’s technology business unit joined employees from Almac’s analytical testing and clinical supplies units as occupants at the North American Headquarters. Over the course of the next two months, Almac will transition the remainder of its clinical supplies operations currently located in Audubon, PA, into the integrated drug development facility in Souderton, PA.
The transition of the technologies business into Almac’s new North American Headquarters was carefully planned and executed. Over the course of the past few months, Almac successfully relocated and tested all of its new and existing technologies and systems in the new locale to make certain that there were no disruptions to client studies during the transition into the North American Headquarters.
Jim Murphy, President of Almac’s clinical technologies business unit, comments on the flawless move of the business from Yardley, PA, to its new location in Souderton, PA. Murphy: “Our IT, Quality Assurance, senior management team, and other key personnel worked in unison to ensure that all of our systems were tested and met the highest standards before we moved into the new facility. The transition team’s meticulous planning enabled us to avoid any downtime on client studies outside of our normal maintenance windows. I am delighted to announce that everything went as planned with this perfectly executed transition.”
The move of three Almac business units to a new North American Headquarters is part of the Almac Group’s integrated services solutions strategy. The new facility was planned to deliver a full-service, integrated drug supply management and technology solution to biopharmaceutical clients.
Joseph Bedford, Ph.D., Director of Marketing at Almac’s Clinical Technologies business unit comments: “The biopharmaceutical industry is making great strides to streamline drug development and bring efficiencies to clinical trials. Our new North American Headquarters allows Almac to deliver an integrated clinical supplies, analytical testing, and clinical technologies offering to sponsors that is unparalleled in our industry. Working with integrated teams of drug supply management and technology specialists at Almac, our clients will benefit from the combined insights of experienced professionals who deliver efficiencies in the clinical supplies chain that no other firm can match.”
